-
UPDATE: Longbow Research Reiterates On Vitamin Shoppe Following 2Q EPS Beat
Wednesday, August 6, 2014 - 9:09am | 175Read More...In a report published Wednesday, Longbow Research analyst Philip Terpolilli reiterated a Buy rating on Vitamin Shoppe (NYSE: VSI), but lowered the price target from $59.00 to $55.00. In the report, Longbow Research noted, “VSI reported adjusted EPS in line with our estimate, along with more stable...
-
Longbow To Investors: Don't Get Excited Over Green Mountain's Keurig Cold Machine Until 2016
Wednesday, February 12, 2014 - 3:06pm | 614Read More...Philip Terpolilli, analyst at Longbow Research, On Wednesday downgraded Green Mountain Coffee Roasters (NASDAQ: GMCR) to Neutral with a price target of $123. Terpolilli explained that the at-home soda consumption market is a $40 billion domestic and $260 billion global market, which is roughly...
